IMPACT Medicom
készítő: IMPACT Medicom
Legújabb epizód
Canadian Hematology Consensus Group: RR FL Consensus Paper Discussion
Canadian Hematology Consensus Group: RR FL Consensus Paper Discussion
A podcastról
We are a medical communications company with a passion for developing high-quality content. We write & design content for healthcare professionals and patients in a variety of therapeutic areas. If you like our podcast, please take the time to rate it and subscribe. See our website for more information, video capsules, and podcasts at: https://www.impactmedicom.com.
Epizódok
A legújabb 20 a(z) 57 epizódból
- Canadian Hematology Consensus Group: RR FL Consensus Paper Discussion · 13 percThe Canadian Hematology Consensus Group, or CHCG, is a national collaboration of Canadian hematologists and healthcare professionals dedicated to improving patient care through…
- Introduction to the Canadian Hematology Consensus Group (CHCG) · 20 percDr. Carolyn Owen, Chair of the Canadian Hematology Consensus Group (CHCG), introduces the CHCG and discusses its mission to develop evidence-based Canadian consensus…
- Double-Exposed CLL/SLL: A Canadian Perspective · 23 percIn this episode with Dr Robert Puckrin, we discuss the unmet needs of double-exposed patients with CLL/SLL, as well as the current and novel treatments that can address this gap…
- Thoracic Surgery Series: Resection after Neoadjuvant Immunotherapy · 10 percIn this podcast episode, Dr. Dimitrios Coutsinos describes a video capsule series involving three educational videos of lung resections using minimally invasive video-assisted…
- Highlights from EHA/ICML 2025: International Perspective on CLL · 41 percIn this podcast episode, we discuss clinical trial updates in chronic lymphocytic leukemia from the 2025 European Hematology Association annual congress in Milan, Italy and the…
- Prise en charge de la PN associée au BV utilisé pour le traitement de première intention du cH · 15 perc(FRENCH) In this podcast episode, which follows this introduction in French, Dr Christopher Lemieux summarizes a paper by Dr Abramson, et al. on the management of Peripheral…
- Management of Peripheral Neuropathy Associated with Brentuximab Vedotin in cHL · 20 percIn this podcast episode, Dr. Michael Chu discusses the management of peripheral neuropathy associated with the use of brentuximab vedotin for the first-line treatment of…
- ASH 2024: Updates on CLL · 27 percIn this podcast episode, Dr. Versha Banerji, a Canadian hematologist from Manitoba and Dr. Jennifer Brown, an internationally renowned hematologist from the United States…
- Integrating Non-Covalent BTK Inhibitors in CLL: Navigating a Rapidly Evolving Treatment Landscape · 18 percIn this podcast episode, Dr. Versha Banerji discusses the role of non-covalent BTK inhibitors for the treatment of CLL. Our Guest: Dr. Versha Banerji is a Clinician Scientist at…
- Highlights from EHA 2024 - Updates on the Treatment of CLL · 42 percIn this podcast episode, three of Canada’s top hematologists discuss data on the treatment of CLL presented at the European Hematology Association (or EHA) meeting in Madrid…
- LIVE FROM EHA 2024 - Sonrotoclax plus Zanubrutinib in R/R CLL · 17 percIn this episode of our podcast, recorded at the European Hematology Association (EHA) meeting in Madrid, Spain, we discuss updated results of the BGB-11417-101 trial with Dr…
- Cutting Edge Advances in the Treatment of Lung Cancer · 15 percIn this episode, Dr. Barbara Melosky discusses cutting edge approaches to the treatment of Lung Cancer, including the use of artificial intelligence and novel therapeutic…
- Precision Medicine Series: Ep15: Biomarkers in Upper GI Cancers · 41 percWelcome to our podcast episode on diagnostic, prognostic and predictive biomarkers for the treatment of upper GI cancers. In this episode, Dr Brezden-Masley (medical oncologist)…
- Management of Cutaneous Squamous Cell Carcinoma (cSCC): A Surgeon’s Perspective · 24 percIn this video capsule, Dr. Mark Taylor discusses the surgical implications for the treatment of cSCC. This podcast episode is best viewed alongside the slides, which can be found…
- Immunotherapy for Kidney Transplant Patients with Skin Cancer · 22 percIn this podcast episode, Dr. Evan Lipson discusses the use of immunotherapy for patients with skin cancer who have had a kidney transplant. Our guest: Dr. Lipson is an…
- LIVE FROM ASH 2023: Isa-CYBORD induction chemotherapy in newly diagnosed, transplant eligible MM · 17 percIn this podcast episode, Dr. Rami Kotb and Dr. Donna Reece discuss results of the CMRG Isa-CYBORD trial presented at the ASH 2023 meeting, and the implications of the results for…
- Live from ASH 2023: Dr Brown Discusses Updated Results of the ALPINE Trial in CLL · 14 percIn this episode of our podcast, recorded at the American Society of Hematology (ASH) in San Diego, California, we discuss updated results of the ALPINE trial with Dr. Jennifer…
- First-line treatment strategies for the management of la/mUC: S2 Ep 5 - ESMO 2023: Discussion on 1L LA/mUC · 32 perc · 2. évad 5. epizódIn this video capsule series, we discuss the first-line treatment strategies for the management of locally advanced metastatic urothelial carcinoma in Canada. This fifth episode…
- First Line la/mUC Evolving Treatment Strategies: S2 Ep 3 - Case Discussion · 8 percIn this podcast series, we discuss the first-line treatment strategies for the management of locally advanced metastatic urothelial carcinoma in Canada. This second part of the…
- First Line la/mUC Evolving Treatment Strategies: S2 Ep 4 - Round Table Discussion · 27 percIn this podcast series, we discuss the first-line treatment strategies for the management of locally advanced metastatic urothelial carcinoma in Canada. This second part of the…
